Safety and hazards of middle-life robotic pancreaticoduodenectomy

Abstract Pancreaticoduodenectomy procedures were performed early in young individuals, with a few days about the risk and survival after robotic pancreaticoduodenectomy. Our goal was to report the results of robotic pancreaticoduodenectomy in patients older than 50 years. Methods Our patients were divided into two groups: younger patients (less than 50 years) and older patients (> 50 years). A total of 1110 patients were included in this study:1004 (90.5%) in the elderly group and 106 (9.5%) in the young group. Results In younger demographics, the prevalence of periampullary cancer is 32.1% as opposed to 76.5%. 2. Tumors biological (15.1% versus 3.6%). 3. Pseudocapillary and solid malignancies (9.4% and 1.0%, respectively). 4. The tissues soft of the pancreas (77.4% vs. 62.5%). There was a higher prevalence of non-dilated (≤ 3 mm) ducts within the pancreas (77.4% vs. 46.3%) in the younger group. 6. Young people group's hospitalization was less (median, 16 vs. 20 days). 7- The younger group fared better after treatment for total periampullary cancers of the with a 5-year prognosis of 76.4% compared to 46.7% in the older category. 8. The results of the other surgeries didn't vary significantly. Conclusions Robotic pancreaticoduodenectomy is associated with favorable survival outcomes for periampullary cancer in younger people (<50 years) and equivalent surgical outcomes compared to older individuals (≥50 years). These outcomes show that robotic pancreaticoduodenectomy is safe and effective in a subset of pediatric patients. Following pancreaticoduodenectomy, the number of juvenile robotic tumor adenocarcinomas